Alyftrek 10-50-125 MG tablet 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FQWF0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,982
Award facts
- Contract value 100% obligated
- $83,981.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $83,981.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alyftrek 10-50-125 mg tablets in quantities of 14. This firm fixed-price delivery order was awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was executed without subcontractor involvement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to military healthcare facilities worldwide. The underlying IDC, designated contract SPE2DR, was awarded on November 13, 2025, with a $500 million ceiling and extends through December 31, 2036, comprising a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's registration as a prime vendor contractor positions it as a critical supplier within the Department of Defense's medical supply chain, authorized to fulfill diverse pharmaceutical requirements including branded and generic prescription medications, biologics, and medical consumables supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQWF0?
SPE2DR26FQWF0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FQWF0 worth?
The government has obligated $83,982 on SPE2DR26FQWF0.
Is contract SPE2DR26FQWF0 an order under another contract?
Yes. SPE2DR26FQWF0 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWF0 competed?
The extent of competition for SPE2DR26FQWF0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award